A prospective, multicenter case-control study published in PLoS Medicine in 2025 described the frequency and clinical characteristics of patients with a protracted post-Covid course and searched for risk factors for persistence vs. improvement of symptoms. The analyses showed that in two thirds of the patients who had a post-Covid syndrome 6-12 months after acute SARS-CoV-2 infection, symptoms persisted in the following months.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- Ischemic stroke: Are smaller or larger brain arteries affected?
Recent study findings on intravenous lysis therapy with fibrinolytic agents
- Interview
“On par with the gold standards for trauma”
- Psychology: Emotional Freedom Techniques (EFT)
Emotional Healing Through Tapping
- Systemic Lupus (SLE): What Does the Diagnosis and Treatment Toolbox Have to Offer?
Treat-to-Target – Consensus Recommendations for GC Tapering and the Use of DMARDs
- Interstitial Lung Diseases
Update on Idiopathic Pulmonary Fibrosis
- Psychedelic-assisted therapy
Current status of PAT
- Psoriasis and Obesity: Effects of Incretin-Based Therapies
Clinical trials shed light on the potential of semaglutide, liraglutide, and tirzepatide
- Non-small-cell lung cancer (NSCLC)